We have recently demonstrated an enhanced expression of inhibitory guanine nucleotide regulatory protein (Gi) in the heart and aorta from spontaneously hypertensive rats (SHR) as compared with control Wistar-Kyoto (WKY) rats; this enhanced G, expression was associated with an increased inhibition of adenylyl cyclase by inhibitory hormones and decreased stimulation of adenylyl cyclase by stimulatory hormones. In the present studies, we have determined the levels of stimulatory and inhibitory guanine nucleotide regulatory proteins (G, and Gi, respectively) in platelets from SHR by cholera toxin-and pertussis toxin-catalyzed ADP-ribosylations, respectively, as well as by immunoblotting techniques using specific antibodies for G, and Gi. Cholera toxin catalyzed the ADP-ribosylation of a single protein of M, 45 000 in rat platelets from SHR and WKY rats, and the labeling of this band was not altered in SHR as compared with WKY rats. Pertussis toxin, on the other hand, catalyzed the ADP-ribosylation of a single protein band of Mr 41 000 in platelets from SHR and WKY rats, and unlike the response in heart and aorta, the labeling of this band was significantly decreased in SHR as compared with WKY rats. Furthermore, immunoblotting experiments using AS/7 antibody, which is specific for G1al and Git,.2 showed a decrease in Gi12 in platelets from SHR as compared with WKY rats. In addition, the inhibitory effects of angiotensin II and atrial natriuretic factor on adenylyl cyclase and cAMP levels were completely abolished in SHR platelets, whereas the stimulatory effects of GTP, N-ethylcarboxamide adenosine, prostaglandin E1, and forskolin on adenylyl cyclase and cAMP levels were enhanced. These results suggest that altered responsiveness of hormones to stimulate or inhibit adenylyl cyclase and cAMP levels in platelets from SHR may partly be attributed to the decreased expression of Gi levels and not to the overexpression of Gs protein.
T he adenylyl cyclase/cAMP system is one of the signal transduction systems implicated in the regulation of cardiovascular functions including arterial tone and reactivity. Several abnormalities in the adenylyl cyclase activities and cAMP levels in cardiovascular tissues of spontaneously hypertensive rats (SHR) have been implicated in the pathogenesis of hypertension.1-3 The adenylyl cyclase system is composed of three components: extracellular receptor, catalytic subunit, and guanine nucleotide regulatory proteins (G proteins). The hormonal stimulation and inhibition of adenylyl cyclase are mediated via two different G proteins: stimulatory (GQ) and inhibitory (G), respectively.4 G proteins are heterotrimeric and composed of three distinct subunits: a, l3, and y.5 The a-subunit (Gsa) binds and hydrolyzes GTP and confers specificity in receptor and effector interactions.6 Two different forms of the Gsa protein with a molecular size of 45 and 52 kD have been characterized.7 However, a third form of the Gsa protein having a molecular size of 47 kD has also been detected in heart.8 These different forms of Gsa arise from several species of mRNA that appear to be the products of alternative splicing of a common precursor.9 10 On the other hand, three distinct forms of GQ, (Gia, Ga,-2, and Gia 3) have been identified and characterized and have been shown to be the products of different genes. The G proteins are also targets of bacterial toxins that are useful probes for defining the interaction of the regulatory proteins with other components of the adenylyl cyclase system. The bacterial toxins such as cholera toxin (CT) and pertussis toxin (PT) catalyze a reaction in which an ADP-ribose is transferred from NAD to specific amino acid acceptors on Gs, or Gi, and a G protein of unknown function (G,), respectively, and thereby modify the characteristics of these proteins. [14] [15] [16] [17] CT irreversibly activates the Gs proteins, which mediate the stimulation of adenylyl cyclase, whereas PT, in addition to GO, acts on the Gi protein, which regulates inhibition and attenuates the GTP-dependent and receptor-mediated inhibition of adenylyl cyclase. 17 The functions of Go are not yet known, but it may interact with enzymes associated with Ca2' mobilization and not with adenylyl cyclase.
The alterations in the expression of G, or Gi have been demonstrated in various pathophysiological conditions, such as heart failure, diabetes, and hypothyroidism. [18] [19] [20] We have recently shown an enhanced expression of Gja2 at protein and mRNA levels and its relation with the adenylyl cyclase inhibition in heart and aorta from SHR and deoxycorticosterone acetate-salt hypertensive rats, whereas the levels of Gsa and GQa mRNA were not altered.21-23 Several abnormalities in platelet functions have been reported in hypertensive patients as well as in SHR; these abnormalities include an abnormal, augmented, or decreased aggregation in response to various stimuli such as ADP, epinephrine, thrombin, prostaglandins, and Ca21 ionophore A23187. [24] [25] [26] [27] Since the adenylyl cyclase/cAMP system has been implicated in platelet aggregation, the observed abnormalities in platelet functions in hypertension may be attributed to the impaired adenylyl cyclase/cAMP system, including G proteins, which play a key role in the regulation of cAMP levels. The present studies were therefore undertaken to investigate the levels of G proteins (Gi and GQ) and their relation with adenylyl cyclase inhibition and stimulation in platelets from SHR. 
Materials and Methods

Preparation of Platelet Membranes
Platelet membranes were prepared as described previously.28 Blood was drawn from femoral arteries of anesthetized rats into citrate anticoagulant containing (mmol/L) sodium citrate, 87; dextrose, 105; citric acid, 11; and Na3P04, 7. A 1-mL portion of anticoagulant was used for each 10 mL of blood. After centrifugation of whole blood at 350g for 10 minutes, platelet-enriched plasma was collected and further centrifuged at 1000g for 10 minutes. The pellet was washed twice with a buffer containing 10 mmol/L Tris and 1 mmol/L EDTA, pH 7.5. Platelet suspensions in 10 mmol/L Tris and 1 mmol/L EDTA were frozen in liquid N2 and stored at -70°C. Before the assay, the frozen platelet suspension was thawed and homogenized, and this freeze thawing was repeated twice.
Adenylyl Cyclase Activity Determination
Adenylyl cyclase activity was determined by measuring [32P]cAMP formation from [a-32P]ATP, as described previously.21'28 The assay medium contained 50 mmol/L glycylglycine (pH 7.5), 0.5 mmol/L Mg-ATP, 1 to 1.5 x 106 cpm [a-'2P]ATP, 5 mmol/L MgCl2 (in excess of the ATP concentration), 100 mmol/L NaCl, 0.5 mmol/L cAMP, 1 mmol/L 3-isobutyl-1-methylxanthine (or oth-GTPyS (or otherwise as indicated), and an ATP-regenerating system consisting of 2 mmol/L creatine phosphate, 0.1 mg creatine kinase per milliliter, and 0.1 mg myokinase per milliliter in a final volume of 200 ,uL. Incubations were initiated by the addition of the membrane preparation (20 to 70 jig protein) to the reaction mixture, which had been thermally equilibrated for 2 minutes at 37°C. The reactions, conducted in triplicate for 10 minutes at 37°C, were terminated by the addition of 0.6 mL of 120 mmol/L zinc acetate containing 0.5 mmol/L unlabeled cAMP. cAMP was purified by coprecipitation of other nucleotides with ZnCO3 and by the addition of 0.5 mL of 144 mmol/L Na2CO3 and subsequent chromatography by the double-column system, as in a total volume of 100 4L. The reaction was terminated by the addition of 20 ,uL of a "stop mix" containing 5% sodium dodecyl sulfate (SDS) and 50% ,3-mercaptoethanol, followed by heating for 10 minutes in a boiling water bath. The labeled proteins were analyzed by subjecting the aliquots to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) by the method of Laemmli34 with 12% SDS-polyacrylamide gels. After electrophoresis, the gels were fixed, stained, destained, dried, and autoradiographed by exposure to Kodak XAR-5 film, as described previously.33 They were calibrated by using molecular weight standards (Pharmacia): phosphorylase b (Mr, 94 000), albumin (Mr, 67 000), ovalbumin (Mr, 43 000; carbonic anhydrase (Mr, 30 000), trypsin inhibitor (Mr, 20 000), and P-lactalbumin (Mr, 14 400). CT-Catalyzed ADP-Ribosylation CT-catalyzed ADP-ribosylation of the membranes from age-matched SHR and WKY rats was performed in a manner similar to that catalyzed by PT except that the CT (500 ,ug/mL) was preactivated for 20 minutes at 37°C in a mixture containing 20 mmol/L dithiothreitol, 1 ,g/mL BSA, and 25 mmol/L KH2PO4 (pH 8.0). For studying the effect of CT on adenylate cyclase activity, the platelet membranes were pretreated with and without CT for 30 minutes at 30°C in the same reaction mixture as described above for ADP-ribosylation except erwise as indicated), 0.1 mmol/L EGTA, 10 
Immunoblotting
After SDS-PAGE, the separated proteins were electrophoretically transferred to nitrocellulose paper (Schleicher & Schuell) using a minitransfer apparatus (Bio-Rad) at 100 V for 1 hour or a semidry transblot apparatus (Bio-Rad) at 15 V for 45 minutes as described previously.21 After transfer, the membranes were washed twice in phosphate-buffered saline (PBS) and were incubated in PBS containing 3% BSA at room temperature for 2 hours. The blots were then incubated with antisera against G proteins in PBS containing 1% BSA and 0.1% Tween 20 at room temperature for 2 hours. The antigen-antibody complexes were detected by incubating the blots with goat anti-rabbit IgG (Bio-Rad) conjugated with horseradish peroxidase for 2 hours at room temperature. The blots were washed three times with PBS before reacting with diaminobenzidine and hydrogen peroxide as described by Hsu and Soban. 35 The autoradiograms and immunoblots were quantified by densitometric scanning using an enhanced laser densitometer (LKB Ultroscan XL, Pharmacia, Quebec, Canada) and gel scan XL evolution software (version 2.1, Pharmacia). The scanning was one dimensional and 
Results
Effect of GTP on Adenylyl Cyclase Activity
Guanine nucleotides stimulate or inhibit the adenylyl cyclase activity by interacting with G proteins. We have recently reported a significant decrease in the sensitivity of guanine nucleotides in the stimulation of adenylyl cyclase activity in heart and aorta from SHR as compared with age-matched normotensive WKY rats.3221 To investigate if such an impaired response of guanine nucleotides to adenylyl cyclase stimulation also exists in platelets from SHR, we studied the effect of GTP on adenylyl cyclase activity, and the results are shown in Fig 1. GTP stimulated the adenylyl cyclase activity in platelets from both SHR and WKY rats in a concentration-dependent manner; however, unlike the response in heart and aorta, the extent of stimulation was greater in SHR than WKY rats. For example, at 10 ,umol/L, GTP stimulated the adenylyl cyclase activity in WKY rats by -20%, whereas -::75% stimulation was observed in SHR. These results indicate that the G, protein may be hypersensitive or overexpressed in SHR.
Hormonal Responsiveness ofAdenylyl Cyclase
If G, is hypersensitive or overexpressed in SHR platelets, the GQ-mediated hormonal effects on adenylyl cyclase should also be augmented. To investigate this possibility, we examined the effects of prostaglandin E, (PGEL) stimulated the enzyme activity to various degrees in SHR and WKY rats; however, the extent of stimulation was higher in SHR as compared with WKY rats. On the other hand, angiotensin II (Ang II) and ANF, which inhibit adenylyl cyclase through Gi, inhibited the enzyme activity by -:'30% and 50%, respectively, in WKY rats, whereas the inhibition was almost completely attenuated in SHR. Fig 3 shows the effect of various concentrations of ANF on adenylyl cyclase in WKY and SHR platelets. ANF, as reported earlier,28 inhibited the adenylyl cyclase activity in platelets from WKY rats in a concentration-dependent manner; the maximal inhibition observed was '=70% with an apparent Ki between 0.1 and 1 nmol/L. However, in SHR, the ANF-mediated inhibition was completely attenuated. Table 1 shows the effect of some hormones and forskolin (FSK) on cAMP levels in platelets from SHR and WKY rats. PGE1, NECA, and FSK increased the cAMP levels in platelets from SHR and WKY rats to various degrees; however, the increases were greater in SHR. For example, NECA and PGE1 increased the cAMP levels by :z-25% and 520%, respectively, in WKY rats and ':"150% and 1240%, respectively, in SHR. Similarly, FSK-stimulated cAMP levels were '-3-fold augmented in SHR as compared with WKY rats (:==23fold increase in SHR as compared with 7-fold increase in WKY rats).
Effect of Hormones on cAMP Levels
On the other hand, inhibitory hormones such as Ang LI and ANF decreased the cAMP levels by '-40% in platelets from WKY rats; however, this inhibitory effect was completely abolished in platelets from SHR. These results indicate that the inhibitory G protein (Gi,), which Platelets from SHR and WKY rats were preincubated with 1 mmol/L Ro 20-1724 (Roche) for 5 minutes at 370C. Various agonists were then added to the cells and were further incubated for 10 minutes. The reaction was stopped by the addition of 6% trichloroacetic acid, and cAMP levels were determined in the supernatant by radioimmunoassay using a kit from Dupont. *P<.001 vs WKY by Student's t test.
mediates the inhibitory effects of hormones on adenylyl cyclase, may be impaired in platelets from SHR.
To investigate whether the hypersensitivity of GQmediated hormonal stimulations were due to the enhanced expression of Gsa, we determined the levels of G, protein by CT-catalyzed ADP-ribosylation and immunoblotting technique using specific antibodies against G, (RM/1). As shown in Fig 4, CT in the presence of [32P]NAD catalyzed the ADP-ribosylation of a single protein band of 45 kD in both WKY and SHR platelets; however, the labeling of this protein band was not different in SHR as compared with WKY rats (WKY rats, 0.40 +0.05 arbitrary units; SHR, 0.39+ 0.04 arbitrary units; n=5) (Fig 4, left) . Similar results were also observed by using specific antibodies against G5, (Fig 4, right) that recognized a protein with a molecular mass of 45 kD in both WKY and SHR platelets, with no alterations in the relative amount of immunodetectable Gsa in SHR as compared with WKY rats (WKY rats, 1.1±0.10 arbitrary units; SHR, 0.98+0.15 arbitrary units; n=5).
These results indicate that the Gs, protein is not altered in platelets from SHR. To corroborate these results with the functions of GQa protein, the effect of CT treatment on the GTP-sensitive adenylyl cyclase was performed in platelets from SHR and WKY rats, and the results are shown in Table 2 . CT treatment augmented the GTPsensitive adenylyl cyclase activity in both WKY and SHR platelets; however, the extent of stimulation was not different in SHR as compared with WKY rats. We also determined the levels of Gia in platelets from SHR and WKY rats by PT-catalyzed ADP-ribosylation and immunoblotting techniques ( Fig 5) to investigate whether the attenuation of inhibitory responses of ANF and Ang II on adenylyl cyclase and cAMP levels were due to the attenuated levels of Gia in SHR. As shown in platelets; however, the labeling of this band was significantly lower (55% to 62%, 60±4%, n=4) in SHR as compared with WKY platelets. Similarly, AS/7 antibodies, which recognize Gia and Ga2,36 recognized a single protein having the molecular mass of 40 kD (Gja 2) in both WKY and SHR platelets, and the relative amount of immunodetectable Gia2 was significantly decreased (40% to 50%, 44+5%, n =4) in SHR as compared with WKY rats (Fig 5, right) .
These results indicate that the expression of Gia2 implicated in adenylyl cyclase inhibition36 is decreased in platelets from SHR. Discussion We3,21,37 and others38,39 have previously reported a decreased sensitivity of various hormones to adenylyl cyclase stimulation in several tissues including heart and aorta from different models of hypertension; this de- Platelet membranes from WKY and age-matched SHR (12 weeks old) were incubated with CT at 30°C for 30 minutes as described in "Materials and Methods," and adenylyl cyclase activity was determined, as described in "Materials and Methods." Right, Immunoblots are from platelet membranes of 12-week-old WKY rats and age-matched SHR. The membrane proteins (40 gg) from WKY rats and SHR were resolved by SDS-PAGE and transferred to nitrocellulose, which was then immunoblotted using AS/7 antibody as described in "Materials and Methods." The detection of the inhibitory G protein a-subunit (Ct40) was performed by using diaminobenzidine and hydrogen peroxide technique as described in "Materials and Methods." The autoradiograms shown are representative of four separate experiments.
crease was associated with a downregulation of the receptor.39' a defective receptor-effector coupling,3 and an enhanced expression of Ga'2' and/or impaired catalytic subunit of adenylate cyclase. However, in the present studies, we demonstrate a differential regulation of adenylyl cyclase by hormones and guanine nucleotides in platelets from SHR. An augmented stimulation of adenylyl cyclase and cAMP levels by GTP, PGEJ, and NECA in SHR as compared with WKY rats is in contrast with the observations made in heart and aorta, where the stimulatory responses of hormones and guanine nucleotides on adenylyl cyclase were significantly attenuated.21 However, these results are in agreement with the studies of Hamet et al,27 who reported a potentiation of the stimulatory effect of PGE, on adenylyl cyclase in platelets from SHR. In addition, the increased responsiveness of adenylyl cyclase to stimulatory hormones has also been demonstrated in splenocytes from SHR.41" The enhanced stimulation of the adenylyl cyclase activity and cAMP formation by PGE, in SHR platelets may explain the augmented attenuation of platelet aggregation by PGE, in SHR. 27 The increased responsiveness of PGE, and NECA to adenylyl cyclase stimulation may be explained by the upregulation of hormone receptors; however, various reports have shown a downregulation or no change in the number of stimulatory hormone receptors in several tissues from various cardiovascular diseases such as hypertension and congestive heart failure.39 Furthermore, our results on the CT-catalyzed ADP-ribosylation and immunoblotting with antibodies against Gsa did not show any alterations in Gsa in SHR as compared with WKY platelets and suggest that Gsa may not be responsible for the augmented ability of GTP, PGEI, and NECA to stimulate adenylyl cyclase in SHR. In addition, the stimulation of the GTP-sensitive adenylyl cyclase activity to a similar extent by CT treatment in SHR and WKY platelets further substantiates the notion that the functions of the Gsa may not be altered in SHR. These results are in agreement with our previous studies demonstrating no alterations in the levels and functions of GSa in the heart and aorta of SHR as compared with WKY rats.21 Similar results have also been reported in the failing human heart.'s However, the decreased functions of GUa in femoral arteries4' and the decreased levels and functions of 6 A decreased labeling of 40/41 kD protein in SHR as compared with WKY platelets by PT-catalyzed ADPribosylation suggests that platelets from SHR have decreased levels of G,a 2 and/or Gia3 proteins and not of Giai or Go, because these proteins have been reported to be absent in platelets. 45 That the levels of Gia2 are decreased in SHR platelets is further substantiated by immunoblotting studies using AS/7 antibodies, which recognized only one protein, G,,2, and the levels of this protein were significantly attenuated in SHR platelets but were not completely abolished. The decreased levels of Gia were also correlated with the decreased function, such as an attenuation of the inhibitory responses of Ang II and ANF on adenylyl cyclase and cAMP levels. However, it appears that a partial decrease in the levels of Gia2 observed in SHR as compared with WKY platelets may be enough to uncouple the receptors from adenylyl cyclase and thereby completely abolish the inhibitory responses of hormones on adenylyl cyclase, or alternatively, some other mechanisms at the receptor level, such as receptor downregulation, may also be responsible for a complete attenuation of inhibitory responses on adenylyl cyclase. In this context, the ANF receptor downregulation in various models of hypertension and congestive heart failure has been demonstrated in various tissues including platelets.4647
Taken together, it is suggested that the decreased levels of Gia2 in SHR platelets may partly be responsible for the attenuated inhibition of adenylyl cyclase by Ang II and ANF in SHR platelets. However, our results indicating decreased levels of Gia2 in SHR platelets are in contrast to the studies reported earlier in SHR tissues such as heart, aorta,21 and brain striatum,48 where the levels of Gia2 were significantly increased in SHR and may suggest that the G proteins are differentially regulated in platelets as compared with the other tissues. This apparent discrepancy may be attributed to the tissue difference. A differential regulation of G proteins in lymphocytes and heart from congestive heart failure has also been reported; the levels of Gs were decreased in lymphocytes and were unaltered in heart. 41, 49 It is also possible that the augmentation of the stimulatory responses of PGE, and NECA on adenylyl cyclase and cAMP levels in SHR platelets in the present studies may also be attributed to the decreased levels of Gi,2. In this regard, it has been demonstrated that PT and amiloride, which inactivate the G, protein, resulted in the augmentation of stimulatory responses of hormones on adenylyl cyclase.33.50 Similarly, the enhanced formation of cAMP by FSK in SHR as compared with WKY platelets in the present studies may be due to the hypersensitivity of the catalytic subunit of the adenylyl cyclase system per se or to the decreased expression of Gia2 or both. The Gi-mediated regulation of FSKstimulated enzyme activity can be further supported by the results of various studies that have been performed involving the effect of PT treatment on adenylyl cyclase activity and that have resulted in an augmentation of the FSK-stimulated enzyme activity.33 Similarly, the overexpression of Gia has also been shown to result in the inhibition of the FSK-stimulated adenylyl cyclase activity.2' On the other hand, the requirement of G, and guanine nucleotides for the FSK activation of adenylyl cyclase has also been reported.5' Since the present increased sensitivity of adenylyl cyclase to FSK stimulation in hypertension cannot be attributed to the G, activity. Taken together, these data indicate that the decreased levels of G,a2 in hypertensive platelets may partly be responsible for the observed augmentation of the FSK-sensitive adenylyl cyclase activity.
In conclusion, we have demonstrated that, unlike the response in heart and aorta, the G protein in platelets is differentially regulated; the expression of Gia2 is decreased in platelets from SHR, whereas the levels of G,, were not altered. The decreased expression of G,,appears to explain, in part, the attenuated responsiveness of adenylyl cyclase to inhibitory hormones and augmented responsiveness to stimulatory hormones and agents that activate adenylyl cyclase by receptor-independent mechanisms. It is suggested that the decreased expression of Gia-2 in platelets from SHR may be one of the mechanisms responsible for the altered platelet aggregation in SHR.
